Reviva Cash from 2010 to 2025
| RVPHW Stock | USD 0.06 0.01 19.05% |
Cash | First Reported 2010-12-31 | Previous Quarter 26.9 M | Current Value 17.7 M | Quarterly Volatility 11.3 M |
Check Reviva Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reviva Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 10 K, Net Interest Income of 602.5 K or Interest Income of 602.5 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 20.25. Reviva financial statements analysis is a perfect complement when working with Reviva Pharmaceuticals Valuation or Volatility modules.
Reviva | Cash |
Latest Reviva Pharmaceuticals' Cash Growth Pattern
Below is the plot of the Cash of Reviva Pharmaceuticals Holdings over the last few years. Cash refers to the most liquid asset of Reviva Pharmaceuticals, which is listed under current asset account on Reviva Pharmaceuticals Holdings balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Reviva Pharmaceuticals customers. The amounts must be unrestricted with restricted cash listed in a different Reviva Pharmaceuticals account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Reviva Pharmaceuticals' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Reviva Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Reviva Cash Regression Statistics
| Arithmetic Mean | 7,805,258 | |
| Geometric Mean | 14,504 | |
| Coefficient Of Variation | 144.45 | |
| Mean Deviation | 9,756,331 | |
| Median | 193.00 | |
| Standard Deviation | 11,275,023 | |
| Sample Variance | 127.1T | |
| Range | 29.7M | |
| R-Value | 0.80 | |
| Mean Square Error | 48.8T | |
| R-Squared | 0.64 | |
| Significance | 0.0002 | |
| Slope | 1,896,734 | |
| Total Sum of Squares | 1906.9T |
Reviva Cash History
Other Fundumenentals of Reviva Pharmaceuticals
Reviva Pharmaceuticals Cash component correlations
Click cells to compare fundamentals
About Reviva Pharmaceuticals Financial Statements
Reviva Pharmaceuticals investors use historical fundamental indicators, such as Reviva Pharmaceuticals' Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Reviva Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash | 26.9 M | 17.7 M | |
| Cash And Short Term Investments | 26.9 M | 17.7 M | |
| Change In Cash | 4.4 M | 3.7 M | |
| Free Cash Flow | -25.5 M | -24.2 M | |
| Begin Period Cash Flow | 21.3 M | 12.6 M | |
| Other Cashflows From Financing Activities | 5.1 M | 3 M | |
| Other Non Cash Items | 215.3 K | 202.1 K | |
| Total Cash From Operating Activities | -25.5 M | -24.2 M | |
| Total Cash From Financing Activities | 38.1 M | 40.1 M | |
| End Period Cash Flow | 26.9 M | 17.7 M | |
| Free Cash Flow Yield | (0.27) | (0.28) | |
| Operating Cash Flow Per Share | (1.37) | (1.44) | |
| Free Cash Flow Per Share | (1.37) | (1.44) | |
| Cash Per Share | 1.13 | 1.07 | |
| EV To Operating Cash Flow | (3.15) | (3.31) | |
| EV To Free Cash Flow | (3.15) | (3.31) | |
| Price To Operating Cash Flows Ratio | (3.89) | (4.09) | |
| Price To Free Cash Flows Ratio | (3.89) | (4.09) | |
| Cash Ratio | 1.56 | 1.49 | |
| Cash Conversion Cycle | (456.91) | (479.76) | |
| Cash Flow Coverage Ratios | (0.05) | (0.05) | |
| Price Cash Flow Ratio | (3.89) | (4.09) | |
| Cash Flow To Debt Ratio | (0.05) | (0.05) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Reviva Stock Analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.